Waters Corporation $WAT Position Lowered by Lbp Am Sa

Key Points

• Lbp Am Sa has reduced its holdings in Waters Corporation by 44.9%, now owning 3,081 shares worth approximately $1,075,000.
• Other institutional investors, including QRG Capital Management and Swedbank AB, have increased their stakes in Waters, indicating strong interest, with institutional ownership now at 94.01%.
• Waters reported $2.95 EPS for the last quarter, surpassing analysts' expectations, while setting guidance for Q3 2025 at 3.150-3.250 EPS and FY 2025 at 12.950-13.050 EPS.

Lbp Am Sa decreased its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 44.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,081 shares of the medical instruments supplier's stock after selling 2,508 shares during the quarter. Lbp Am Sa's holdings in Waters were worth $1,075,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. QRG Capital Management Inc. raised its stake in Waters by 85.7% during the first quarter. QRG Capital Management Inc. now owns 1,642 shares of the medical instruments supplier's stock worth $605,000 after acquiring an additional 758 shares during the period. Swedbank AB raised its stake in Waters by 25.8% during the second quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier's stock worth $14,145,000 after acquiring an additional 8,305 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Waters by 5.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier's stock worth $195,599,000 after acquiring an additional 28,018 shares during the period. Cambridge Investment Research Advisors Inc. raised its stake in Waters by 4.6% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,986 shares of the medical instruments supplier's stock worth $1,101,000 after acquiring an additional 130 shares during the period. Finally, Jacobs Levy Equity Management Inc. acquired a new stake in Waters during the first quarter worth about $1,244,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Price Performance

NYSE WAT opened at $321.60 on Friday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The firm has a market capitalization of $19.14 billion, a PE ratio of 29.00, a P/E/G ratio of 2.98 and a beta of 1.04. The company's 50 day simple moving average is $296.39 and its 200 day simple moving average is $325.96.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same quarter last year, the business earned $2.63 earnings per share. The business's revenue for the quarter was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities research analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the stock a "buy" rating in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a "hold" rating in a research note on Tuesday, August 5th. Wells Fargo & Company dropped their price target on shares of Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a research note on Tuesday, August 5th. Bank of America raised their price target on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Finally, UBS Group restated a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $380.43.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.